The drug-product Afresa developed by mannkind corporation has recently been approved by the FDA for use in type 1 and 2 diabetes in the treatment of hyperglycemia.The drug is insulin therapy that is delivered through an inhalation device called Afresa.It is described on the company website as being an ultra rapid acting mealtime insulin therapy.The advantage of this device will be its ability to be synchronized easily around meals which would make it much easier for diabetes sufferers.....
For details visit company websites,they is no indication when the drug will be in the market place but granted it was approved in may 2009 it should be on pharmacy shelves soon......take care all
Reference
http://www.mannkindcorp.com/afresa-background.aspx
No comments:
Post a Comment